These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27743567)

  • 61. Surveillance liver MRI for monitoring patients with known or suspected chronic liver disease.
    Pozzessere C; Porter KK; Kamel IR
    Clin Radiol; 2017 Jan; 72(1):93.e7-93.e13. PubMed ID: 27687630
    [No Abstract]   [Full Text] [Related]  

  • 62. [Modern magnetic resonance imaging of the liver].
    Hedderich DM; Weiss K; Maintz D; Persigehl T
    Radiologe; 2015 Dec; 55(12):1045-56. PubMed ID: 26628259
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gadolinium-enhanced MR imaging of the spleen: artifacts and potential pitfalls.
    Ito K; Mitchell DG; Honjo K; Fujita T; Awaya H; Takano K; Koike S; Matsumoto T; Matsunaga N
    AJR Am J Roentgenol; 1996 Nov; 167(5):1147-51. PubMed ID: 8911169
    [No Abstract]   [Full Text] [Related]  

  • 64. Diagnostic Imaging of the Hepatobiliary System: An Update.
    Marolf AJ
    Vet Clin North Am Small Anim Pract; 2017 May; 47(3):555-568. PubMed ID: 28069288
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diffuse liver disease: strategies for hepatic CT and MR imaging.
    Boll DT; Merkle EM
    Radiographics; 2009 Oct; 29(6):1591-614. PubMed ID: 19959510
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contrast-Enhanced Ultrasound in Focal Liver Lesions: Where Do We Stand?
    Bartolotta TV; Vernuccio F; Taibbi A; Lagalla R
    Semin Ultrasound CT MR; 2016 Dec; 37(6):573-586. PubMed ID: 27986175
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Modern visualization of the liver with MRT. Current trends and future perspectives].
    Zech CJ; Schoenberg SO; Herrmann KA; Dietrich O; Menzel MI; Lanz T; Wallnöfer A; Helmberger T; Reiser MF
    Radiologe; 2004 Dec; 44(12):1160-9. PubMed ID: 15549227
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: explanation and potential clinical applications for color-coded qualitative and quantitative analysis.
    Wang L; Van den Bos IC; Hussain SM; Pattynama PM; Vogel MW; Krestin GP
    Acta Radiol; 2008 Feb; 49(1):6-18. PubMed ID: 18210307
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Focal liver lesions: role of contrast-enhanced ultrasound.
    Rettenbacher T
    Eur J Radiol; 2007 Nov; 64(2):173-82. PubMed ID: 17900841
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Liver imaging].
    Helmberger T
    Radiologe; 2017 May; 57(5):346-347. PubMed ID: 28255788
    [No Abstract]   [Full Text] [Related]  

  • 71. Design and characterization of magnetic resonance imaging gene reporters.
    Louie A
    Methods Mol Med; 2006; 124():401-17. PubMed ID: 16506432
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Overhauser-enhanced MRI.
    Golman K; Leunbach I; Petersson JS; Holz D; Overweg J
    Acad Radiol; 2002 May; 9 Suppl 1():S104-8. PubMed ID: 12019840
    [No Abstract]   [Full Text] [Related]  

  • 73. Targeted MRI contrast agents for pediatric hepatobiliary disease.
    Courtier JL; Perito ER; Rhee S; Tsai P; Heyman MB; MacKenzie JD
    J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):454-62. PubMed ID: 22193178
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Imaging efficacy of a hepatocyte-selective polyiodinated triglyceride (DHOG-LE) for contrast-enhanced CT.
    Doerr-Stevens JK; Bakan DA; Lee FT; Chosy SG; Markhardt BK; Bonneville AK; Burrascano C; Delaney C; Longino MA; Greener Y; Weichert JP
    Acad Radiol; 2002 May; 9 Suppl 1():S200-4. PubMed ID: 12019869
    [No Abstract]   [Full Text] [Related]  

  • 75. Pearls and Pitfalls of Metabolic Liver Magnetic Resonance Imaging in the Pediatric Population.
    Mojtahed A; Gee MS; Yokoo T
    Semin Ultrasound CT MR; 2020 Oct; 41(5):451-461. PubMed ID: 32980092
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Update on Imaging Contrast Agents.
    Zamora CA; Castillo M
    Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):xiii-xiv. PubMed ID: 28964470
    [No Abstract]   [Full Text] [Related]  

  • 77. Case 246.
    Shruti A; Wu GS
    Radiology; 2017 Jun; 283(3):906-908. PubMed ID: 28514224
    [No Abstract]   [Full Text] [Related]  

  • 78. American Institute ofUltrasound in Medicine recommendations for contrast-enhanced liver ultrasound imaging clinical trials.
    Greenbaum L; Burns P; Copel J; Cosgrove D; Fowlkes JB; Goldberg B; Mattrey R; Merton D; Robbin M; Wilson S;
    J Ultrasound Med; 2007 Jun; 26(6):705-16. PubMed ID: 17526602
    [No Abstract]   [Full Text] [Related]  

  • 79. MR Imaging of Chronic Liver Diseases and Liver Cancer.
    Elsayes KM; Sirlin CB
    Magn Reson Imaging Clin N Am; 2021 Aug; 29(3):xvii-xviii. PubMed ID: 34243931
    [No Abstract]   [Full Text] [Related]  

  • 80. Improved means of correcting motion blurring in scintigraphic images.
    McKeighen RE
    Phys Med Biol; 1979 Mar; 24(2):353-62. PubMed ID: 450976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.